High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$162M
$162,268,437
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-11 | $5,125,647Whalex12 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-10 | $5,127,273Whalex17 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-09 | $4,921,275Largex20 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-06 | $4,537,853Largex13 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-05 | $4,603,232Largex9 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-04 | $6,041,414Whalex12 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-03 | $4,744,467Largex16 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-02 | $4,896,019Largex18 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -23.5%
2025-12-19
$1,014,143Largex2
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -23.5%
|
2025-12-19 | $1,014,143Largex2 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -23.5%
2025-12-18
$2,035,488Largex3
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -23.5%
|
2025-12-18 | $2,035,488Largex3 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -36.3%
2025-12-17
$2,004,147Largex2
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -36.3%
|
2025-12-17 | $2,004,147Largex2 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -60.5%
2025-12-16
$1,973,820Largex3
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -60.5%
|
2025-12-16 | $1,973,820Largex3 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -12.1%
2025-12-15
$1,978,869Largex2
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -12.1%
|
2025-12-15 | $1,978,869Largex2 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -26.6%
2025-12-12
$1,962,783Largex2
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -26.6%
|
2025-12-12 | $1,962,783Largex2 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -36.3%
2025-12-11
$1,935,879Largex3
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -36.3%
|
2025-12-11 | $1,935,879Largex3 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.4%
2025-12-08
$1,936,936Largex5
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.4%
|
2025-12-08 | $1,936,936Largex5 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -72.6%
2025-12-05
$1,933,120Largex2
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -72.6%
|
2025-12-05 | $1,933,120Largex2 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -34.0%
2025-12-04
$1,920,043Largex2
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -34.0%
|
2025-12-04 | $1,920,043Largex2 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -32.7%
2025-12-03
$1,901,087Largex3
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -32.7%
|
2025-12-03 | $1,901,087Largex3 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -16.0%
2025-12-02
$1,925,143Largex4
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -16.0%
|
2025-12-02 | $1,925,143Largex4 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -38.5%
2025-12-01
$1,927,703Largex4
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -38.5%
|
2025-12-01 | $1,927,703Largex4 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -19.4%
2025-11-28
$1,950,550Largex4
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -19.4%
|
2025-11-28 | $1,950,550Largex4 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -51.7%
2025-11-26
$1,940,204Largex3
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -51.7%
|
2025-11-26 | $1,940,204Largex3 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -37.2%
2025-11-25
$1,901,305Largex3
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -37.2%
|
2025-11-25 | $1,901,305Largex3 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -60.5%
2025-11-24
$1,883,114Largex2
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -60.5%
|
2025-11-24 | $1,883,114Largex2 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -27.8%
2025-11-21
$1,898,558Largex3
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -27.8%
|
2025-11-21 | $1,898,558Largex3 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.2%
2025-11-20
$1,913,524Largex3
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.2%
|
2025-11-20 | $1,913,524Largex3 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -48.4%
2025-11-19
$1,898,336Largex2
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -48.4%
|
2025-11-19 | $1,898,336Largex2 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -36.3%
2025-11-18
$1,891,037Largex3
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -36.3%
|
2025-11-18 | $1,891,037Largex3 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -36.3%
2025-11-17
$1,870,192Largex2
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -36.3%
|
2025-11-17 | $1,870,192Largex2 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -12.1%
2025-11-14
$1,851,774Largex4
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -12.1%
|
2025-11-14 | $1,851,774Largex4 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -18.4%
2025-11-13
$2,915,859Largex4
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -18.4%
|
2025-11-13 | $2,915,859Largex4 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -12.1%
2025-11-12
$1,839,996Largex6
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -12.1%
|
2025-11-12 | $1,839,996Largex6 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -26.6%
2025-11-11
$1,807,283Largex3
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -26.6%
|
2025-11-11 | $1,807,283Largex3 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -79.4%
2025-11-10
$1,793,546Largex2
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -79.4%
|
2025-11-10 | $1,793,546Largex2 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -18.6%
2025-11-07
$1,793,008Largex3
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -18.6%
|
2025-11-07 | $1,793,008Largex3 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -64.3%
2025-11-06
$1,794,308Largex2
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -64.3%
|
2025-11-06 | $1,794,308Largex2 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -12.1%
2025-11-05
$1,751,922Largex5
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -12.1%
|
2025-11-05 | $1,751,922Largex5 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -12.1%
2025-11-04
$1,736,501Largex3
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -12.1%
|
2025-11-04 | $1,736,501Largex3 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -12.0%
2025-11-03
$1,753,194Largex5
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -12.0%
|
2025-11-03 | $1,753,194Largex5 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -17.2%
2025-10-31
$1,801,398Largex3
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -17.2%
|
2025-10-31 | $1,801,398Largex3 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -20.6%
2025-10-30
$1,795,837Largex4
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -20.6%
|
2025-10-30 | $1,795,837Largex4 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -26.6%
2025-10-29
$1,743,112Largex3
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -26.6%
|
2025-10-29 | $1,743,112Largex3 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -23.8%
2025-10-28
$1,661,555Largex3
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -23.8%
|
2025-10-28 | $1,661,555Largex3 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.2%
2025-10-27
$1,662,173Largex3
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.2%
|
2025-10-27 | $1,662,173Largex3 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -47.2%
2025-10-24
$1,696,259Largex3
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -47.2%
|
2025-10-24 | $1,696,259Largex3 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -60.5%
2025-10-23
$1,688,730Largex3
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -60.5%
|
2025-10-23 | $1,688,730Largex3 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -15.3%
2025-10-22
$1,688,607Largex3
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -15.3%
|
2025-10-22 | $1,688,607Largex3 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -26.3%
2025-10-21
$1,711,043Largex4
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -26.3%
|
2025-10-21 | $1,711,043Largex4 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2025-10-20 | $1,698,350Largex5 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -70.2%
2025-10-17
$1,722,687Largex2
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -70.2%
|
2025-10-17 | $1,722,687Largex2 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -36.3%
2025-10-16
$1,725,253Largex3
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -36.3%
|
2025-10-16 | $1,725,253Largex3 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.2%
2025-10-15
$1,741,164Largex3
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.2%
|
2025-10-15 | $1,741,164Largex3 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -12.6%
2025-10-14
$1,749,874Largex3
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -12.6%
|
2025-10-14 | $1,749,874Largex3 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.2%
2025-10-13
$1,761,730Largex2
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.2%
|
2025-10-13 | $1,761,730Largex2 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.2%
2025-10-10
$1,778,788Largex2
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.2%
|
2025-10-10 | $1,778,788Largex2 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.2%
2025-10-09
$1,795,655Largex3
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.2%
|
2025-10-09 | $1,795,655Largex3 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -29.8%
2025-10-08
$1,803,449Largex4
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -29.8%
|
2025-10-08 | $1,803,449Largex4 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.2%
2025-10-07
$1,807,320Largex3
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.2%
|
2025-10-07 | $1,807,320Largex3 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.2%
2025-10-06
$1,798,765Largex2
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.2%
|
2025-10-06 | $1,798,765Largex2 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.2%
2025-10-03
$1,784,847Largex3
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.2%
|
2025-10-03 | $1,784,847Largex3 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -48.4%
2025-10-02
$1,739,525Largex2
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -48.4%
|
2025-10-02 | $1,739,525Largex2 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -26.1%
2025-10-01
$1,701,797Largex3
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -26.1%
|
2025-10-01 | $1,701,797Largex3 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -96.8%
2025-09-30
$1,691,358Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -96.8%
|
2025-09-30 | $1,691,358Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2025-09-29 | $1,702,527Largex4 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.2%
2025-09-26
$1,712,891Largex2
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.2%
|
2025-09-26 | $1,712,891Largex2 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -21.8%
2025-09-25
$1,723,739Largex3
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -21.8%
|
2025-09-25 | $1,723,739Largex3 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -80.3%
2025-09-24
$1,736,489Largex2
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -80.3%
|
2025-09-24 | $1,736,489Largex2 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -48.4%
2025-09-23
$1,672,593Largex2
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -48.4%
|
2025-09-23 | $1,672,593Largex2 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -48.4%
2025-09-22
$1,669,213Largex2
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -48.4%
|
2025-09-22 | $1,669,213Largex2 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -96.8%
2025-09-19
$1,644,310Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -96.8%
|
2025-09-19 | $1,644,310Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -48.4%
2025-09-18
$1,617,665Largex3
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -48.4%
|
2025-09-18 | $1,617,665Largex3 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -75.9%
2025-09-17
$1,600,687Largex2
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -75.9%
|
2025-09-17 | $1,600,687Largex2 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.2%
2025-09-16
$1,601,062Largex2
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.2%
|
2025-09-16 | $1,601,062Largex2 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -61.5%
2025-09-15
$1,591,536Largex2
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -61.5%
|
2025-09-15 | $1,591,536Largex2 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.2%
2025-09-12
$1,615,900Largex3
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.2%
|
2025-09-12 | $1,615,900Largex3 | S | Form 4 |